Ostrum Asset Management Vertex Pharmaceuticals Inc Transaction History

Ostrum Asset Management

$1.21 Trillion
Q3 2024

A detailed history of Ostrum Asset Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ostrum Asset Management holds 5,273 shares of VRTX stock, worth $2.45 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

5,273

Previous 7,428 29.01%

Holding current value

$2.45 Million

Previous $3.48 Billion 29.56%

% of portfolio

0.2%

Previous 0.3%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $991,300 - $1.09 Million	-2,155 Reduced 29.01%	5,273 $2.45 Billion
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $743,589 - $919,108	-1,893 Reduced 20.31%	7,428 $3.48 Billion
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $6,115 - $6,691	15 Added 0.16%	9,321 $3.9 Billion
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $163,611 - $195,894	477 Added 5.4%	9,306 $3.79 Billion
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $20,290 - $21,747	-60 Reduced 0.67%	8,829 $3.07 Billion
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $2,515 - $2,815	8 Added 0.09%	8,889 $3.13 Billion
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $1.28 Million - $1.46 Million	-4,524 Reduced 33.75%	8,881 $2.8 Billion
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $258,206 - $306,131	1,010 Added 8.15%	13,405 $3.65 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $383,316 - $502,860	1,700 Added 15.9%	12,395 $3.6 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $219,747 - $272,591	1,100 Added 11.46%	10,695 $2.55 Million
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $149,607 - $168,381	900 Added 10.35%	9,595 $1.63 Million
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $829,963 - $959,845	5,042 Added 138.02%	8,695 $1.59 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $554,927 - $702,143	3,653 New	3,653 $605,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.

Account

Ostrum Asset Management Vertex Pharmaceuticals Inc Transaction History